Atlas Trials

Measuring the Effects of Netarsudil, Latanoprost, and Combination Therapy on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma Suspects

Clinical trial NCT04401982 · RECRUITING

Trial details

NCT number
NCT04401982
Sponsor
University of Maryland, Baltimore
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Ocular HypertensionSuspect Glaucoma
Start date
2026-07-02
Primary completion
2027-03-17
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.